A
$ Value
$0
Shares
33,000
Price
$0
Filed
Jan 22
Insider
Name
Robins Jason Shand
Title
Interim CFO
CIK
0002104600
Roles
Officer
Transaction Details
Transaction Date
2026-01-20
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
33,000
Footnotes
Subject to the reporting person's continued service to the Corporation, the shares underlying this option vest over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant.
Filing Info
Robins Jason Shand's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-01-20 | OCUL | A | $0 |
Other Insiders at OCUL (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| LINDSTROM RICHARD L MD | $461K | — | 2026-02-20 |
|
Heier Jeffrey S.
Chief Scientific Officer
|
— | $25K | 2026-02-23 |
|
Dugel Pravin
See Remarks
|
— | $1.3M | 2026-04-09 |
|
Notman Donald
Chief Operating Officer
|
— | $205K | 2026-02-12 |
|
Kaiser Peter
Chief Development Officer
|
— | $23K | 2026-02-23 |
|
Nayak Sanjay
Chief Strategy Officer
|
— | $108K | 2026-02-23 |
|
Waheed Nadia
Chief Medical Officer
|
— | $98K | 2026-02-20 |
|
Robinson David Wayne
Global CCO
|
— | — | 2026-01-21 |